Evidence map›Paper›PMID 30082288›Full record

ArticleAntimicrobial agents and chemotherapy2018

First Clinical Isolation of an Azole-Resistant Aspergillus fumigatus Isolate Harboring a TR46 Y121F T289A Mutation in South America.

Guillermina Isla, Florencia Leonardelli, Iris N Tiraboschi, Nicolás Refojo, Alejandra Hevia, Walter Vivot, Wanda Szusz, Susana B Córdoba, Guillermo García-Effron

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
    Review
  2. Article
  3. Uncovering a NovelJournal of fungi (Basel, Switzerland) · 2024
    Article
  4. Review
  5. Studies in mycology · 2021
    Review
  6. Triazole-Resistance in EnvironmentalJournal of fungi (Basel, Switzerland) · 2021
    Article
  7. Emergence of Triazole Resistance inCurrent fungal infection reports · 2021
    Review
  8. A Novel Combination ofAntimicrobial agents and chemotherapy · 2020
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guillermina IslaDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Florencia LeonardelliLaboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.
Iris N TiraboschiHospital de Clínicas José de San Martín, Buenos Aires, Argentina.
Nicolás RefojoDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Alejandra HeviaDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Walter VivotDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Wanda SzuszDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Susana B CórdobaDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Guillermo García-EffronLaboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina ggarcia@unl.edu.ar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most recently described

Indexed as

Antifungal AgentsAspergillus fumigatusAzolesDrug Resistance, FungalFungal ProteinsMutationSouth AmericaAntifungal AgentsAzolesFungal ProteinsAspergillus fumigatusazoleCYP51AresistanceSouth AmericaTR46TR46 Y121F T289A mutation

Identifiers

PMID30082288
PMCPMC6153829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.